Matches 1 - 50 out of 261 1 2 3 4 5 6 >
Match Document Document Title
7381725 Pyridazine derivatives as ligands for GABA receptors  
A class of pyridazine derivatives, substituted in the 4-position by an optionally substituted heteroaromatic ring, being selective ligands for GABAA receptors, in particular having high affinity...
7348327 Compounds  
The present invention relates to new, potent DPP-IV enzyme inhibitors of the general formula (I), which contain fluorine atoms.
7320977 Substituted 2-phenyl-3(2h)-pyridazinones  
The invention relates to substituted 2-Phenyl-3(2H)-Pyridazinones, to a method for the production thereof, and to their use as medicaments for the prophylaxis and/or treatment of diseases in humans...
7294627 Chemical compounds  
Compounds of formula (I) in which R 1 , R 2 , R 3 and R 4 , have the meanings given in the specification are Factor Xa inhibitors useful in the treatment of thrombotic disorders.
7294625 Pyrazole compounds  
The present invention relates to pyrazole compounds represented by the formula (I): wherein R 1 represents phenyl which may be substituted, R 2 represents H, halogen, alkyl, alkoxy,...
7259157 N-substituted nonaryl-heterocyclo amidyl NMDA/NR2B Antagonists  
Compounds represented by Formula (I): or pharmaceutically acceptable salts thereof, are effective as NMDA NR2B antagonists useful for relieving pain.
7256192 Aromatic diamide derivatives, chemicals for agricultural or horticultural use and usage thereof  
The present invention relates to an aromatic diamide derivative represented by the general formula (I): [A 1 is optionally substituted (C 1 -C 8 )alkylene group, (C 3 -C 8 )alkenylene...
7241758 Compounds useful as anti-inflammatory agents  
Disclosed are novel aromatic compounds of the formula (I) wherein G, X, Ar, L and Q are defined herein. The compounds are useful in pharmaceutic compositions for treating diseases or pathological...
7217706 Propanolamine derivatives  
This invention relates to new propanolamine derivatives or salts thereof represented by the following formula [I]: Wherein each symbol is as defined in the specification or salts thereof which...
7214678 Arylsulfanyl and heteroarylsulfanyl derivatives for treating pain  
According to the invention there is provided a compound the formula I; wherein A, X, B, R 1 , R 2 , R 3 and R 4 are as defined in the specification.
7211577 Water-soluble phenylpyridazine derivative and medicine containing the same  
A phenylpyridazine derivative represented by the formula (1): Wherein, R1, R2, R3, X, Y, Z and n have the same meaning as defined in the specification; or a salt thereof, or a medicine...
7205301 Microbiocidal N-phenyl-n-[4-(4-pyridyl)-2-pyrimidin-2-yl]-amine derivatives  
Fungicidal compounds of Formula (I) wherein m is 0, 1, 2 or 3; n and p are independently of each other 0 or 1; R 1 is halogen, optionally substituted alkyl, optionally substituted alkoxy,...
7183283 Piperidinyl-alkylamino-pyridazinone derivatives, a process for the preparation thereof and pharmaceutical compositions containing said compounds  
The invention relates to new piperidinyl-alkylamino-pyridazinone derivatives of the general Formula (I) (wherein R is hydrogen or C 1-4 -alkyl; one of X and Y stands for hydrogen and the other...
7176204 Substituted carboxylic acid derivatives  
Novel substituted carboxylic acid derivatives which bind as ligands to human peroxisome proliferator activated receptor (PPAR) to activate the receptor and thereby exhibit potent effects of...
7166604 Antiviral agents  
This invention relates to compounds of formula I their salts, and pharmaceutically acceptable derivatives thereof, pharmaceutical compositions comprising these compounds and their use in the...
7135471 Aryl oximes  
Aryl oxime derivatives of the formula (I), in which R 1 , R 2 , R 3 , X and B are as defined in claim 1 , act as phosphodiesterase IV inhibitors and can be employed for the treatment of...
7129243 Peptide compounds  
The present invention relates to a compound of the formula (I) wherein R1 is benzofuranyl substituted by halogen, or styryl substituted by halogen; R2 is substituted hydroxy, substituted mercapto...
7129241 Pyridazine derivatives  
Pyridazine derivatives of the formula (I) act as phosphodiesterase IV inhibitors and can be employed for the treatment of osteoporosis, tumours, cachexia, atherosclerosis, rheumatoid arthritis,...
7122546 Imidazol-1-ylmethyl pyridazine derivatives  
The invention provides imidazol-1-ylmethyl pyridazine derivatives of the formula: that bind to GABA A receptors. In the above formula, R 1 , R 2 R 3 , R 4 , R 5 , R 6 and Ar are defined...
7098211 Compounds having simultaneous ability to block L-type calcium channels and to inhibit phosphodiesterase type 3 activity  
The present invention provides compounds that possess inhibitory activity against PDE-3 and L-type calcium channels. The present invention further provides pharmaceutical compositions comprising...
7098210 2h-pyridazine-3-one derivatives, pharmaceutical compositions containing the same and a process for the preparation of the active ingredient  
The invention refers to novel 2H-pyridazine-3-one derivatives of the formula I, pharmaceutical compositions containing the same and a process for the preparation of the active ingredient. The novel...
7081468 Ortho-substituted anthranilic acid amides and their use as medicaments  
Ortho-substituted anthranilic acid amides and use thereof as pharmaceutical agents for treating diseases that are triggered by persistent angiogenesis are described.
6903101 Substituted pyridazines and fused pyridazines with angiogenesis inhibiting activity  
Substituted and Fused pyridazines having angiogenesis inhibiting activity and the generalized structural formula wherein the ring containing A, B, D, E, and L is a nitrogen-containing...
6894041 Oxazolyl-acid amide derivatives useful as inhibitors of PDE4 isozymes  
This application is directed to compounds useful as inhibitors of PDE4 in the treatment of diseases regulated by the activation and degranulation of eosinophils, especially asthma, chronic...
6869945 Pyrrolyl-and imidazolyl-acid amide derivatives useful as inhibitors of PDE4 isozymes  
This application is directed to compounds useful as inhibitors of PDE4 in the treatment of diseases regulated by the activation and degranulation of eosinophils, especially asthma, chronic...
6867206 6-carboxyphenyldihydropyridazinone derivatives and use thereof  
The present invention relates to 6-carboxyphenyldihydropyridazinone derivatives having the formula wherein R 1 , R 2 , R 3 , A, D, G, and E are as defined in the specification and claims, a...
6831083 Pyrazoline derivative or tetrahydropyridazine derivative and medicinal use thereof  
Using a compound selected from compounds represented by the following formula (1) (which include 3-phenyl-2-pyrazoline derivatives and 3-phenyl-tetrahydropyridazine derivatives) and...
6800628 N-substituted 4-((-4′-aminobenzoyl)-oxymethyl)-piperidines having gastric prokinetic properties  
This invention concerns the compounds of formula the N-oxide forms, the pharmaceutically acceptable acid addition salts and the stereochemically isomeric forms thereof, wherein R 1 is C 1-6...
6787546 Heterocycle derivatives and drugs  
The object of the invention is to provide an excellent compound as a drug. The invention relates to a heterocyclic compound shown by the following formula: A—B—D—E [ 1] wherein A is...
6777412 Fungicides  
The invention provides fungicidal compounds of formula (I) or stereoisomers thereof: wherein X is CH 2 O; A is hydrogen; E is hydrogen; q is 1; any two of K, L and M are nitrogen and the other...
6759414 Aromatic amides  
This application relates to a compound of formula I (or a pharmaceutically acceptable salt thereof) as defined herein, pharmaceutical compositions thereof, and its use as an inhibitor of factor Xa,...
6730672 Aminoheterocyclic derivatives as antithrombotic or anticoagulant agents  
The invention concerns compounds of formula (I) wherein each of G 1 , G 2 and G 3 is CH or N; m is 1 or 2; R 1 includes hydrogen, halogeno and (1-4C)alkyl; M 1 is a group of the formula: NR...
6696437 Heterocyclically substituted benzimidazoles, the production and application thereof  
The present invention relates to novel benzimidazoles, their preparation and their use as inhibitors of the enzyme poly(ADP-ribose) polymerase or PARP (EC 2.4.2.30) for producing drugs.
6689780 Heteroroaromatic amides as inhibitor of factor Xa  
This application relates to heteroaromatic amides (or a pharmaceutically acceptable salt thereof) as defined herein, pharmaceutical compositions thereof, and its use as an inhibitor of factor Xa,...
6680316 Pyridazin-3-one derivatives and medicines containing the same  
Objects of the invention are to provide compounds having excellent activity against interleukin-1β production and also medicines comprising them as effective ingredients. Pyridazin-3-one...
6677354 Piperdines for use as orexin receptor antagonists  
Disclosed are compounds of formula (I): wherein: Y represents a group (CH 2 ) n , wherein n represents 0, 1 or 2; R 1 is phenyl, naphthyl, a mono or bicyclic heteroaryl group containing up to 3...
6676932 Ultraviolet absorbent, photostabilizer, ultraviolet ray-absorbing composition, photostabilized composition and external preparation for skin  
Providing an ultraviolet absorbent or photostabilizer with excellent absorption over a wide ultraviolet wavelength range and great stability and a high safety profile, as well as an...
6664256 Phenylpyridazine compounds and medicines containing the same  
Phenylpyridazine compounds represented by the following formula (I): are provided, wherein R 1 , R 2 , R 3 , R 4 , and n are as defined herein having excellent inhibitory activity against...
6624166 Pyridazines as interleukin-1β converting enzyme inhibitors  
Disclosed are compounds of the formula (I) and pharmaceutically acceptable salts thereof: wherein R 1 is a halogen, or an oxygen linked leaving group including an aromatic ether, an alkyl...
6617325 Biphenyl derivatives, production thereof and uses as medicines  
The present invention relates to biphenyl derivatives of general formula wherein R a to R g and n are defined as in claim 1, the isomers and salts thereof, particularly the physiologically...
6602889 5-heteroaryl substituted indoles  
The present invention relates to compounds having general formula (I) as defined herein, or a pharmaceutically acceptable acid addition salt thereof. The compounds are selective α 1 -adrenoceptor...
6602872 Substituted pyridazines having cytokine inhibitory activity  
There are disclosed compounds of formula (I) and pharmaceutically acceptable salts thereof which exhibit utility for the treatment of cytokine mediated diseases such as arthritis.
6602871 Thrombin or factor Xa inhibitors  
This invention relates generally to inhibitors of trypsin-like serine protease enzymes, especially factor Xa or thrombin, pharmaceutical compositions containing the same, and methods of using the...
6593346 N-cyclopentyl modulators of chemokine receptor activity  
The present invention is directed to compounds of the formula I: (wherein R 1 , R 3 , R 4 , R 5 , R 6 , R 7 , R 8 , X, n, x and y are defined herein) which are useful as modulators of chemokine...
6569860 Alkoxycarbonylamino heteroaryl carboxylic acid derivatives as IP antagonists  
This invention relates to compounds which are IP receptor antagonists and which are represented by Formula (I): wherein G 2 is a heteroaryl group containing one or two nitrogen atoms...
6562824 Dihydropyridine soft drugs, and related compositions and methods  
This invention relates to novel dihydropyridine soft drugs of the formula ΦOOR 1 , where Φ is a dihydropyridine moiety. These compounds are useful as calcium channel antagonists with...
6548520 Substituted imidazoles having anti-cancer and cytokine inhibitory activity  
The present invention is related to novel 2-alkyl substituted imidazoles of formula (I) useful for the treatment of CSBP kinase mediated diseases.
6514974 Pyrido-, pyrimido-, pyridazo- and pyrazo- pyridazines having angiogenesis inhibiting activity  
The invention relates to compounds of formula I, wherein r is 0 to 2, n is 0 to 2; m is 0 to 4; R 1 and R 2 (i) are in each case a lower alkyl, or (ii) together form a bridge in subformula I* ...
6498161 Pyrrolidine modulators of chemokine receptor activity  
The present invention is directed to pyrrolidine compounds of the formula I: (wherein R 1 , R 2 , R 3 , R 4 , R 5 , R 6 and n are defined herein) which are useful as modulators of chemokine...
6479494 Arylalkanoyl pyridazines  
Arylalkanoylpyridazine derivatives of the formula I and the physiologically acceptable salts thereof in which R 1 , R 2 , R 3 , R 4 , Q and B have the meanings given in Claim 1 act as...
Matches 1 - 50 out of 261 1 2 3 4 5 6 >